administration of the lhrh agonist , nafarelin ( d- ( nal2 ) 6 gnrh ) , at a dosage of 200 micrograms twice daily intranasally in 13 patients with uterine leiomyomata resulted in a reduction in uterine volume to a mean of 55.1 % at 3 months and 44.5 % at 6 months as measured using ultrasound .
C0064906
nafarelin
C0023610
gnrh